PMV Pharmaceuticals
PMVP
PMVP
105 hedge funds and large institutions have $775M invested in PMV Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
12.57% more ownership
Funds ownership: 121.56% → 134.13% (+13%)
6% more funds holding
Funds holding: 99 → 105 (+6)
33% less capital invested
Capital invested by funds: $1.15B → $775M (-$375M)
Holders
105
Holding in Top 10
6
Calls
$6.6M
Puts
$1.49M
Top Buyers
| 1 | +$37.1M | |
| 2 | +$24.4M | |
| 3 | +$19.5M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$15.2M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$12.8M |
Top Sellers
| 1 | -$26.3M | |
| 2 | -$23.1M | |
| 3 | -$22.4M | |
| 4 |
Morgan Stanley
New York
|
-$18.6M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$16.3M |